|Targets||Toll-like Receptor (TLR)|
|Description||AL-034 is a Toll-like receptor 7 (TLR7) agonist in a phase I clinical trial for the treatment of HBV infections.|
|Brife Description||TLR7 agonist, HBV infections|
|Application||the potential treatment of HBV infections|
Imiquimod maleate is an immune response modifier. It acts as a toll-like receptor 7 agonist. It is commonly used topically to treat warts on the skin of the gen...
CU-CPT-9a is a TLR8 antagonist with an IC50 of 0.5 nM.
Agonist of TLR9; An immunomodulating synthetic oligonucleotide; As a monotherapy and in combination with chemotherapeutic agents, and also as an adjuvant for va...
CPG52364 sulfate is the sulfate form of CPG52364, which is a small molecule toll-like receptor(TLR) antagonist. It has recently completed phase 1 clinical trial...
A potent TLR7 agonist (EC50 = 7.2 nM)
CU CPT 4a
Selective TLR3 inhibitor(IC50 = 3.44 μM in RAW 264.7 cells)
CU-CPT-9m is a TLR8 antagonist with an IC50 of 67 nM.
Pam2CSK4 Biotin is the biotinylated Pam2CSK4. Pam2CSK4, a synthetic diacylated lipopeptide (LP), is a toll-like receptor 2/6 (TLR2/6) agonist, and induces TNF-α...